iShares iBonds Dec 2035 Term Corporate ETF · Other
3m RS is unavailable, Market Stance is 49.9
As of 2026-08-21, iShares iBonds Dec 2035 Term Corporate ETF (IBCA) has a 3-month relative strength percentile of — within the TickerStance CS+ADRC universe (~5,000 tickers). The current market Stance is 49.9 (Neutral). Sector: Other. Average daily range 0.3%, relative volume 8.02×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
| # | Holding | Weight | Value |
|---|---|---|---|
| 1 | Meta Platforms, Inc. | 1.73% | $6M |
| 2 | Oracle Corp. | 1.11% | $4M |
| 3 | Alphabet, Inc. | 0.84% | $3M |
| 4 | Amazon.com, Inc. | 0.82% | $3M |
| 5 | Broadcom, Inc. | 0.81% | $3M |
| 6 | Broadcom, Inc. | 0.73% | $2M |
| 7 | Synopsys, Inc. | 0.71% | $2M |
| 8 | AT&T, Inc. | 0.70% | $2M |
| 9 | AbbVie, Inc. | 0.68% | $2M |
| 10 | Verizon Communications, Inc. | 0.65% | $2M |
| 11 | Verizon Communications, Inc. | 0.62% | $2M |
| 12 | Charter Communications Operating LLC | 0.59% | $2M |
| 13 | Marsh & McLennan Cos., Inc. | 0.58% | $2M |
| 14 | Caterpillar, Inc. | 0.52% | $2M |
| 15 | Medtronic, Inc. | 0.51% | $2M |
| 16 | Global Payments, Inc. | 0.51% | $2M |
| 17 | Takeda US Financing, Inc. | 0.51% | $2M |
| 18 | Merck & Co., Inc. | 0.50% | $2M |
| 19 | Rio Tinto Finance USA plc | 0.50% | $2M |
| 20 | AbbVie, Inc. | 0.49% | $2M |
| 21 | Oracle Corp. | 0.47% | $2M |
| 22 | Waste Management, Inc. | 0.47% | $2M |
| 23 | Arthur J Gallagher & Co. | 0.47% | $2M |
| 24 | MPLX LP | 0.45% | $2M |
| 25 | CVS Health Corp. | 0.45% | $2M |
Showing 25 of 416 holdings.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Daily range, ATR, beta, and the math for a 1-ADR stop.
No attention data for this ticker yet — it joins the daily scan once a baseline builds.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | IBCA Jan avg: 0.12% median: 0.12% win: 100% σ: 0.00% n: 1 2025-03-27 → 2026-07-31 | IBCA Feb avg: 1.14% median: 1.14% win: 100% σ: 0.00% n: 1 2025-03-27 → 2026-07-31 | IBCA Mar avg: -0.83% median: -0.83% win: 50% σ: 2.18% n: 2 2025-03-27 → 2026-07-31 | IBCA Apr avg: 0.04% median: 0.04% win: 100% σ: 0.06% n: 2 2025-03-27 → 2026-07-31 | IBCA May avg: -0.00% median: -0.00% win: 50% σ: 0.16% n: 2 2025-03-27 → 2026-07-31 | IBCA Jun avg: 0.80% median: 0.80% win: 50% σ: 1.46% n: 2 2025-03-27 → 2026-07-31 | IBCA Jul avg: -1.27% median: -1.27% win: 0% σ: 1.07% n: 2 2025-03-27 → 2026-07-31 | IBCA Aug avg: 0.78% median: 0.78% win: 100% σ: 0.00% n: 1 2025-03-27 → 2026-07-31 (current) | IBCA Sep avg: 1.32% median: 1.32% win: 100% σ: 0.00% n: 1 2025-03-27 → 2026-07-31 | IBCA Oct avg: -0.04% median: -0.04% win: 0% σ: 0.00% n: 1 2025-03-27 → 2026-07-31 | IBCA Nov avg: 0.69% median: 0.69% win: 100% σ: 0.00% n: 1 2025-03-27 → 2026-07-31 | IBCA Dec avg: -1.03% median: -1.03% win: 0% σ: 0.00% n: 1 2025-03-27 → 2026-07-31 |